Last week the ABPI published the Disclosure UK database listing details of the fees and benefits in kind paid by the pharmaceutical industry to doctors, pharmacists, nurses, and healthcare organisations.
However, only healthcare professionals and organisations consenting to being identified were named, and the remainder of the information was published in aggregate form.
Data shows that only 70% of medical professionals in receipt of payments from companies agreed to have the data disclosed. However the 30% who did not agree to disclosure received 52% of the payments registered.
GMC says it can’t force doctors to disclose payments from drug companies, The BMJ 354/bmj.i3806, 07 July 2016.
The UK General Medical Council has admitted that it does not have the legal power to force doctors to disclose details of payments and benefits they receive from the pharmaceutical industry.